Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Otello Corporation announces first quarter results

Oslo, Norway - May 7, 2020 - Otello Corporation today reported financial results for the first quarter, which ended March 31, 2020. Please find the first quarter report (1Q20.pdf) and first quarter presentation (1Q20_presentation.pdf) attached. Audiocast: https://www.otellocorp.com/ir Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their

Results from pivotal phase 2/3 study of emapalumab in patients with primary HLH published in New England Journal of Medicine

Sobi™  announced today that the results from the pivotal phase 2/3 study evaluating the efficacy and safety of emapalumab in patients with primary haemophagocytic lymphohistiocytosis (HLH) were published in the New England Journal of Medicine on 7 May 2020. Emapalumab is the first therapy approved by the US Food & Drug Administration (FDA) for primary HLH and is under review by the European Medicines Agency (EMA). Primary HLH is a rare syndrome that typically presents in infancy but can also be seen in adults and is associated with high morbidity and mortality. This

Targovax ASA: First quarter 2020 results

Oslo, Norway, 7 May 2020 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its first quarter 2020 results. An online presentation by Targovax's management to investors, analysts and the press will take place at 10:00 CET today (details below). HIGHLIGHTS FOR THE FIRST QUARTER 2020 · Entered into an option agreement with IOVaxis Therapeutics for an TG mutant RAS vaccine license and clinical development agreement in China · Presented encouraging data in the mesothelioma study

Nel ASA: First quarter 2020 financial results

(Oslo, 7 May 2020) Nel ASA (Nel) reported revenues of NOK 126.5 million in the first quarter of 2020, slightly up from NOK 122.4 million in the same quarter of 2019 and an adjusted EBITDA of negative NOK 41.7 million. The order backlog grew 46% to NOK 590 million and the company currently holds approximately NOK 1.3 billion in cash. Nel expects the Covid-19 pandemic to continue to impact financial results, but reiterates the long-term outlook.  “As we communicated in the our Covid-19 market updates 22 and 26 March, in addition to 21 April, Nel implemented strict regulations to ensure

Odfjell SE 1Q20: Improved results despite a market facing several uncertainties

Odfjell SE today reported its results for the first quarter of 2020. The report shows improved results driven by increased earnings in Odfjell Tankers as a consequence of an improved chemical tanker market. This led to positive underlying net results for Odfjell SE. Highlights for 1Q20 · EBITDA of USD 66 million, compared to USD 58 million in 4Q19 · EBITDA of USD 58 million from Odfjell Tankers compared to USD 50 million in 4Q19 · EBITDA of USD 8 million from Odfjell Terminals compared to USD 8 million in  4Q19 · Net result of USD -4 million compared to USD -10 million in

Kojamo plc: Kojamo plc’s Interim Report 1 January – 31 March 2020

Kojamo Plc Stock Exchange Release, 7 May 2020 at 8:00 a.m. EESTKojamo plc’s Interim Report 1 January – 31 March 2020 Growth in the first quarter and 1,651 Lumo apartments under construction This is a summary of the Interim Report January–March 2020, which is in its entirety attached to this release and can be downloaded from the company’s website at www.kojamo.fi/investors. Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year. The figures in this Interim Report have not been audited. Summary of January–March 2020 ·

Filo Mining Reports Q1 2020 Results

Vancouver, May 6, 2020 /CNW/: Filo Mining Corp. (TSXV: FIL) (Nasdaq First North Growth Market: FIL) ("Filo Mining" or the "Company") is pleased to announce its results for the three months ended March 31, 2020.  HIGHLIGHTS: CONTINUED EXPLORATION SUCCESS AT FILO DEL SOL The 2018/2019 field season proved transformational for the Company, proving the existence of a significant porphyry copper-gold system underlying Filo del Sol’s current Mineral Resource. Following up on that success, the Company planned and executed an exploration program during the 2019/2020 field season to further

Africa Energy Reports First Quarter 2020 Results

VANCOUVER, May 6, 2020 /CNW/ – Africa Energy Corp. (TSX Venture: AFE) (Nasdaq First North: AEC) (“Africa Energy” or the “Company”), an oil and gas company with exploration assets offshore South Africa and Namibia, announces financial and operating results for the three months ended March 31, 2020. Garrett Soden, the Company’s President and CEO, commented: “Our robust financial position--$26 million in cash, no debt and lean overhead--will allow us to weather the current economic environment brought on by the emergence of the coronavirus pandemic. We continue to focus on cost control and

Etrion to Release First Quarter 2020 Results on May 8, 2020

May 6, 2020, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, will release its first quarter 2020 results before the market opens on Friday, May 8, 2020.   Operations and Finance Update call   A conference call webcast to present the Company’s first quarter 2020 Operations and Finance update will be held on Monday, May 11, 2020, at 10:00 a.m. Eastern Standard Time (EST) / 4:00 p.m. Central European Time (CET).    Dial-in details:  Conference ID: 2070058 North America: +1-647-788-4919 / Toll Free:

Bulletin from the 2020 Annual General Meeting (AGM) of Aspire Global PLC

Today, May 6th 2020, the Annual General Meeting (AGM) of Aspire Global adopted the Consolidated Financial Statements for the 2019 fiscal year, discharged the Board of Directors and CEO from liability and re-elected the Board of Directors and the Chairman until the end of the next AGM. The AGM also resolved on four extraordinary resolutions related to the procedures for General Meetings and the authorization of the Company to acquire its own shares, including the required amendments of the Company’s articles of association. The attendants at the AGM represented 68.4% of the votes in the

Minor correction regarding calculation of key ratios

In the interim report for the first quarter 2020 that was published by Hoist Finance on 6 May 2020, there was a minor error in the calculation of the key ratios Return on Equity and Earnings per share. The correction refers to the deduction of interest expenses on AT1 capital instruments. It does not have an impact on any other key ratios nor on the Financial statements for the quarter. Return on Equity is corrected from -7 per cent to -6 per cent. Return on Equity, excluding items affecting comparability, is corrected from 5 per cent to 4 per cent. Basic and diluted Earnings per

Possible vaccine for virus linked to type 1 diabetes

According to many observations, certain virus infections may play a part in the autoimmune attack that leads to type 1 diabetes. Researchers at Karolinska Institutet in Sweden and their Finnish colleagues have now produced a vaccine for these viruses in the hope that it could provide protection against the disease. The study is published today in the scientific journal Science Advances.While an estimated 50,000 Swedes live with type 1 diabetes (sometimes known as juvenile diabetes), the causes of the disease remain unknown. There is a genetic component, but also environmental factors are

S&P Global downgrades Rikshem’s long-term rating one notch to BBB+

The credit rating agency S&P Global today announced that they downgrade Rikshem’s long-term rating one notch to BBB+ with stable outlook. Short-term rating A-2 and K-1 on S&P’s Nordic scale are affirmed.In February, S&P Global (S&P) announced that they had placed Rikshem on Credit Watch Negative due to Rikshem's updated ownership directives and new financial targets. Now, S&P has decided to apply their rating criteria “Key Credit Factors for the Real Estate Industry” instead of as previously “Methodology for Rating Public and Nonprofit Social Housing Providers” on Rikshem. As a consequence,

Electrolux Professional plans to apply for a delisting of Electrolux Professional’s series A shares

Electrolux Professional AB (publ) plans to apply for a delisting of the company’s series A shares as the company, following contacts with Nasdaq Stockholm, has been informed of an insufficient liquidity in the series A share resulting in a dysfunctional pricing. An application for delisting will only concern to the series A shares, and will not affect the company’s series B shares. Holders of Electrolux Professional’s series A shares can request conversion of their series A shares into series B shares.e company has rhe liquidity The company has requested a statement from the Swedish

Report from Enea AB’s Annual General Meeting 2020

Stockholm, Sweden, May 6, 2020 Enea® (Nasdaq Stockholm: ENEA) The annual general meeting of Enea AB (publ) (the "Company"), was held on Wednesday 6 May 2020, 4.30 p.m. at Kista Science Tower, Färögatan 33 in Kista, Stockholm. The following was decided by the annual general meeting (“AGM”): Adoption of the profit and loss account and the balance sheetThe AGM adopted the profit and loss accounts and the balance sheets of the Parent Company and the Group for the financial year 2019. DividendThe AGM resolved that no dividend will be paid. Board of Directors and auditorsThe

Resolutions at Pharmacolog AB’s (publ) annual general meeting 2020

The shareholders of Pharmacolog in Uppsala AB (publ) held the Annual General Meeting on May 6, 2020 in Uppsala. (information below in Swedish only)ÅrsredovisningÅrsredovisning och revisionsberättelse framlades och resultat- och balansräkningen fastställdes. Det beslutades att disponera bolagets resultat i enlighet med styrelsens förslag.AnsvarsfrihetStämman beslutade att lämna ansvarsfrihet åt styrelseledamöterna och verkställande direktören.ArvodenStyrelsearvodet fastställdes med 150 000 kronor till ordföranden och 100 000 kronor vardera till övriga ledamöter som inte är

Odfjell SE: Annual General Meeting 2020 – Minutes

The Annual General Meeting of Odfjell SE was held on May 6, 2020. All items according to the agenda dated April 7, 2020, were approved. Election of the Board Pursuant to the Company's Article of Association, three of the current six members of the Board were up for election at the General Meeting. The General Meeting re-elected Laurence Ward Odfjell (Chair), Christine Rødsæther and Jannicke Nilsson as board members for a period of two years. Attached please find the minutes from the Annual General Meeting 2020.

Resolutions at the Annual General Meeting of Loomis AB (publ)

At today's Annual General Meeting of Loomis AB (publ) the following was resolved: Board of Directors and auditorThe Annual General Meeting resolved that the number of Board members shall be six with no deputy members. The Meeting re-elected Alf Göransson, Lars Blecko, Cecilia Daun Wennborg, Johan Lundberg and Jan Svensson as Board members. Jeanette Almberg was elected as new Board member. Alf Göransson was re-elected Chairman of the Board. The fee to the Board members was determined to a total of SEK 3,725,000 (including fees for committee work) apportioned so that the Chairman of the

The Board withdraws the proposal regarding long-term incentive program

Gothenburg 6 May 2020 The Board for Azelio AB (publ) has decided to withdraw the previously communicated proposal to the Annual General meeting 2020 regarding a long-term incentive program to the CEO and certain members of the executive management in Azelio, in total eight persons. The reason for the decision is that the Board believe that the program should be extended with respect to the number of warrants that can be offered to the participants in the program. The Board will call for an extra general assembly and propose that the extra assembly decides on a revised long-term

The Board of Investment AB Latour (publ) decides on revised proposal for dividend

Investment AB Latour (publ) has followed the development of the global Covid-19 pandemic and its impact on Latour's holdings. The Group’s financial position remains strong, and both in Latour's wholly-owned operations and in the investment portfolio companies, extensive measures have been implemented to address the uncertain market situation. In the Quarterly Report for the fourth quarter 2019 and in the Annual Report 2019, the Board has communicated its proposal of a dividend of SEK 2.75 per share for the financial year 2019. Due to the fact that the majority of Latour’s listed

Paradox Interactive AB enables the shareholders to use digital postal voting ahead of the Annual General Meeting 2020

Paradox has decided that shareholders are able to exercise their voting rights for the 2020 Annual General Meeting through digital postal voting. Paradox urges shareholders to use this option in order to minimize the number of people who will physically attend the meeting, thereby helping to reduce the risk of spreading the Coronavirus (Covid-19).Shareholders can, through May 11, 2020, exercise the option to digital postal voting via this link https://esign.simplesign.io/online/289911/Poströsta. Shareholders who exercise their voting rights through digital postal voting do not need to

Report from the Annual General Meeting of Proact IT Group AB (publ)

The Annual General Meeting of Proact IT Group AB (publ) was held on 6 May 2020 as stated in the notice to attend.The following decisions were made at the Annual General Meeting: · The income statement and balance sheet, and the consolidated income statement and consolidated balance sheet were approved and adopted. · Establishment of the Board’s proposal that no dividends are paid for the financial year 2019 and that the profit is carried forward. · The Board of Directors and Managing Director were granted discharge from liability for the financial year 2019. · A decision

Peab’s Annual General Meeting 2020

At the AGM held on Wednesday Peab’s shareholders adopted the income statement and balance sheet, decided disposition of the company's profits, election of, and remuneration to, the Board of Directors and auditor as well as election of the Nomination Committee. The AGM also authorized the Board to decide on issues and transfers of shares and adopted Peab’s new Remuneration Policy and changes in the articles of association.The AGM approved the Board’s revised proposal to not distribute a dividend for the financial year of 2019 due to the uncertainty created by the spread of coronavirus.

There are no items matching the current filter
There are no more items matching the current filter
Back to top